CD4+ T-cell-mediated anti-tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis (Q39865699)

15 September 2017

title

CD4+ T-cell-mediated anti-tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis (English)

1 reference

15 September 2017

4

1 reference

15 September 2017

Jonathan L Bramson

5

0 references

author name string

Sheng Zhang

1

1 reference

15 September 2017

Dannie Bernard

2

1 reference

15 September 2017

Waliul I Khan

3

1 reference

15 September 2017

Yonghong Wan

6

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

European Journal of Immunology

15 September 2017

published in

1 reference

15 September 2017

volume

39

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

1252-1259

1 reference

Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

CD4 cells can be more efficient at tumor rejection than CD8 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Inhibition of angiogenesis by interleukin 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

CD4+ T cell--mediated tumor rejection involves inhibition of angiogenesis that is dependent on IFN gamma receptor expression by nonhematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

The role of STAT6 in mast cell IL-4 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

How microorganisms tip the balance between interleukin-12 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Induction and effector functions of T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Differentiation and function of Th17 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Stat3 and Stat4 direct development of IL-17-secreting Th cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

GADD45beta/GADD45gamma and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNgamma production in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Signal transducer and activator of transcription 6 controls chemokine production and T helper cell type 2 cell trafficking in allergic pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

Elevated Frequencies of Self-reactive CD8+ T Cells following Immunization with a Xenoantigen Are Due to the Presence of a Heteroclitic CD4+ T-Cell Helper Epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

The risk of autoimmunity associated with tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

7 January 2021

Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

7 January 2021

Peripheral blood CD4+ T-cell response before postoperative active immunotherapy correlates with clinical outcome in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

7 January 2021

STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839152

7 January 2021

Identifiers

DOI

10.1002/EJI.200839152

1 reference

15 September 2017

1 reference